William Blair Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Buy
1,317
+6
+0.5% +$1.58K ﹤0.01% 386
2026
Q1
$350K Buy
1,311
+34
+3% +$9.21K ﹤0.01% 390
2025
Q4
$320K Sell
1,277
-107
-8% -$28.4K ﹤0.01% 399
2025
Q3
$397K Sell
1,384
-48
-3% -$12.9K ﹤0.01% 378
2025
Q2
$376K Sell
1,432
-22
-2% -$5.36K ﹤0.01% 392
2025
Q1
$338K Sell
1,454
-597
-29% -$145K ﹤0.01% 400
2024
Q4
$470K Hold
2,051
﹤0.01% 392
2024
Q3
$458K Sell
2,051
-165
-7% -$36.3K ﹤0.01% 379
2024
Q2
$451K Buy
2,216
+197
+10% +$40.1K ﹤0.01% 374
2024
Q1
$441K Buy
2,019
+78
+4% +$17.2K ﹤0.01% 372
2023
Q4
$441K Sell
1,941
-32
-2% -$6.72K ﹤0.01% 364
2023
Q3
$397K Buy
+1,973
New +$416K ﹤0.01% 374
2022
Q1
Sell
-771
Closed -$208K 449
2021
Q4
$208K Buy
+771
New +$191K ﹤0.01% 421

Other funds holding LH

William Blair Investment Management's LH Position: Q2 2026 in Review

William Blair Investment Management increased its Labcorp (LH) stake by 0.46% in Q2 2026, buying an estimated $1.58K and bringing the position to 1,317 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

William Blair Investment Management first reported a position in LH in Q4 2021 and has held it in 13 quarters since. The position peaked at $470K in Q4 2024. 1,055 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • William Blair Investment Management held 1,317 shares of Labcorp worth $369K as of Q2 2026.
  • William Blair Investment Management bought 6 Labcorp shares in Q2 2026, an estimated $1.58K.
  • Labcorp made up ﹤0.01% of William Blair Investment Management's portfolio in Q2 2026, its #386 holding.
  • William Blair Investment Management first reported a position in Labcorp in Q4 2021 and has held it in 13 quarters since.
  • William Blair Investment Management's Labcorp position peaked at $470K in Q4 2024.
  • 1,055 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.